Circulating lipoprotein(a) levels and steatotic liver disease related to metabolic dysfunction in adults: an updated systematic review and meta-analysis
A. Mustafa·Ioannis Kyrou·Lukasz Lagojda·Chris Kite·Farah Abdelhameed·Kamaljit Chatha·Anirudh Suresh·Harpal S. Randeva·Alexander Dallaway
Background Metabolic dysfunction-associated steatotic liver disease (MASLD), previously defined as non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD), is the leading cause of chronic liver disease worldwide, with a pathophysiological spectrum ranging from steatosis to steatohepatitis and fibrosis. Lipoprotein(a) [Lp(a)] is an atherogenic lipoprotein, which is associated with increased cardiovascular disease (CVD) risk and has been recently r